In rheumatology, the next generation of new therapies always seems to be just out of reach, or perpetually “only a few years” away. However, several novel, and not-so-novel, approaches are giving hope that the future may finally soon arrive.Such...
In rheumatology, the next generation of new therapies always seems to be just out of reach, or perpetually “only a few years” away. However, several novel, and not-so-novel, approaches are giving hope that the future may finally soon arrive.
Such approaches include the Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway, as well as agents that target the neonatal fragment crystallizable receptor or blood dendritic cell antigen 2, or stimulate the human programmed cell death protein 1.
Specifically, according to experts, multiple approved molecules and a